Management of refractory ascites and hepatorenal syndrome.
Refractory ascites and hepatorenal syndrome (HRS) are the late complications of the terminal stages of cirrhosis. The definitions of refractory ascites and HRS proposed by the International Ascites Club in 1996 are now widely accepted, and are useful in diagnosis, treatment and research in this field. In both conditions, the only treatment of proven value for improved survival is liver transplantation. However, because of better understanding about the pathophysiology of HRS, including the roles of portal hypertension, ascites formation and hemodynamic derangements, treatments such as transjugular intrahepatic portasystemic shunt (TIPS) and new pharmacological agents may be considered to alleviate the problem prior to transplantation. Symptomatic treatment of refractory ascites includes TIPS and repeated large volume paracentesis. Transjugular intrahepatic portasystemic shunt can improve survival while waiting for liver transplantation. Practical management guidelines for TIPS and large volume paracentesis, including the prevention and management of further complications, are considered in this review.
Chutaputti
Anuchit
A
Section of Digestive and Liver Diseases, Department of Medicine, Phramongkutklao Hospital, Bangkok, Thailand. anchitcp@med.pmk.ac.th
D001201:Ascites / Q000628:therapy*; D006530:Hepatorenal Syndrome / Q000628:therapy*; D006801:Humans; D019152:Paracentesis; D019168:Portasystemic Shunt, Transjugular Intrahepatic